🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPharmacology & MechanismsGIP receptor pharmacology — anyone have experience? Page 7

GIP receptor pharmacology — anyone have experience?

Dr.RaviCardio Sat, Jan 10, 2026 at 8:15 AM 38 replies 1,386 viewsPage 7 of 8
matt_MKE
Member
312
1,345
Sep 2024
Milwaukee, WI
Jan 17, 2026 at 6:13 AM#31
Dr.PathRoch said:
If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way.

Bookmarking. The distinction being drawn above is the one nobody else makes. Adding it to my notes with a link back to this thread.

1 24andrew_nyc
Reply Quote Save Share Report
JenPlateau
Member
234
890
Nov 2024
Missouri
Jan 17, 2026 at 12:32 PM#32

Adding the clinical framing, because it changes how the question reads. It is worth asking what the claim would look like if it were false. If nothing would look different, it is not a claim about the world and no amount of discussion will settle it.

2 0TrialNerd_Beth, HPLC_Greg
Reply Quote Save Share Report
DeniseRN_TPA
Member
345
1,567
Aug 2024
Tampa, FL
Jan 17, 2026 at 6:51 PM#33
JenPlateau said:
It is worth asking what the claim would look like if it were false.

Adding a me-too, because a thread of one person's experience is not much use. Nothing to add that would improve it.

Last edited: Jan 17, 2026 at 9:51 PM
3 1tommy_boulder, hyun_seoul, jim_asheville
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
carlos_SATX
Member
245
1,123
Oct 2024
San Antonio, TX
Jan 18, 2026 at 1:10 AM#34
JenPlateau said:
It is worth asking what the claim would look like if it were false.

There is a second half to this that has not been said yet. The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either. Those three things can all be true at once, and most arguments here are two people holding different parts of that.

Happy to go further on any of that.

4 2LindaRN_retired, tommy_boulder, hyun_seoul and 1 other
Reply Quote Save Share Report
anders_CPH
Senior Member
1,567
7,234
Feb 2024
Copenhagen, DK
Jan 18, 2026 at 7:30 AM#35

One concrete data point for the thread. One habit that pays for itself: post the method alongside the number. A figure without its method cannot be checked, and an unchecked figure is how this community accumulates folklore.

If somebody has the primary source to hand I would rather cite it than paraphrase it.

5 3ChrisMacros, KetoKyle, CanadaChris and 2 others
Reply Quote Save Share Report

Similar Threads

GLP-1R desensitization — β-arrestin-mediated internalization18 replies
Biased agonism at GLP-1R — Gs vs β-arrestin signaling balance13 replies
Semaglutide albumin binding and the C-18 fatty acid linker17 replies
GIP receptor pharmacology — why GIP agonism enhances GLP-113 replies
Glucagon receptor signaling — hepatic glycogenolysis and lipolysis16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register